Decoy Therapeutics Inc. Common Stock

DCOYNASDAQ • USD
0.83 USD
↘ 0.04 (4.68%)AT CLOSE (03:59 PM EST)
0.84
↗ 0.01 (1.64%)
POST MARKET (AS OF 06:53 PM EST)
Post Market
AS OF 06:53 PM EST
0.84
↗ 0.01 (1.64%)
🟢Market: OPEN

Shares of Decoy Therapeutics Inc. Common Stock (DCOY) are trading at $0.84. The technical outlook is "Sell" based on moving average alignment, RSI, and MACD signals. This is driven by negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest DCOY is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 20, 2026.

Open?$0.86
High?$0.87
Low?$0.80
Prev. Close?$0.87
Volume?38.0K
Avg. Volume?56.7K
VWAP?$0.84
Rel. Volume?0.67x
Bid / Ask
Bid?$0.69 × 100
Ask?$0.98 × 100
Spread?$0.29
Midpoint?$0.83
Valuation & Ratios
Market Cap?2.1M
Shares Out?2.4M
Float?581.3K
Float %?98.5%
P/E Ratio?N/A
P/B Ratio?0.46
EPS?-$6.94
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.
Employees
11
Market Cap
2.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2015-01-29
Address
2450 HOLCOMBE BLVD
HOUSTON, TX 77021
Phone: 346-772-0346
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestHigh
Short % of Float?17.16%High
Short Interest?99.7K
Days to Cover?1.8
Free Float581.3K
Avg Daily Volume54.7K
Settlement Date2026-10-30
Financial Health
Current Ratio?1.97Adequate
Quick Ratio?1.97Adequate
Cash Ratio?1.92Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
92/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.46CHEAP▾
P/S?
Peers
100
S&P
39
3.88FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.4CHEAP▾
EV/Sales?
S&P
97
-11.39CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-364.3%WEAK▾
ROA?
S&P
3
-188.4%WEAK▾
Cash Flow & Enterprise
FCF?$-9964794
Enterprise Value?$-6092876
Fundamentals ratios updated end of day